期刊文献+

免疫抑制剂与器官移植 被引量:1

下载PDF
导出
摘要 目前临床上常用的免疫抑制药包括:(1)微生物酵解产物,如环孢素A(CsA)、他克莫司(Tac)、西罗莫司(SRL);(2)抗核酸代谢类药物,如硫唑嘌呤(AZA)、6-巯基嘌呤(6-MP)、吗替麦考酚酯(MMF);(3)皮质激素类药物,如泼尼松;(4)单克隆抗体,如巴利昔单抗、达利珠单抗、莫罗莫单抗;(5)烷化剂类药物,如环磷酰胺。在尚无法获得可操作免疫耐受的今天,
出处 《内蒙古中医药》 2012年第9期24-24,共1页 Inner Mongolia Journal of Traditional Chinese Medicine
  • 相关文献

参考文献2

二级参考文献9

  • 1Pascual M,Theruvath T,Kawai T,et al.Strategies to improve long-term outcomes after renal transplantation.N Engl 0J Med,2002,346(8):580-590.
  • 2Nankivell BJ,Borrows RJ,Fung CL,et al Calcineurin inhibitor nephrotoxicity:longitudinal assessment by protocol histology.Transplantation,2004,78(4):557-565.
  • 3Nankivell BJ,Borrows RJ,Fung CL,et al.The natural history of chronic allograft nephropathy.N Engl J Med,2003,349 (24):2326-2333.
  • 4Sabatini S,Ferguson RM,Helderman JH,et aL Drug substitution in transplantation:a National Kidney Foundation White Paper.Am J Kidney Dis,1999,33(2):389-397.
  • 5Substitution of critical dose drugs:Issues,analysis,and decision making.American Pharmaceutical Association,2000.
  • 6Mill n O,Urtasun N,Brunet M.Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients.Transplant Rev (Orlando),2009,23(2):120-128.
  • 7de Jonge H,Kuypers DR.Pharmacogenetics in solid organ transplantation:current status and future directions.Transplant Rev (Orlando),2008,22(1):6-20.
  • 8Sombogaard F,van Schaik RH,Mathot RA,et aL.Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type Ⅱ 3757T》C polymorphism.Pharmacogenet Genomics,2009,19(8):626-634.
  • 9Thervet E,Anglicheau D,Legendre C,et al.Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.Ther Drug Monit,2008,30(2):143-150.

共引文献1

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部